Skip to main content

Artificial Chemical Neural Network for Drug Discovery Applications

  • Conference paper
  • First Online:
Artificial Life and Evolutionary Computation (WIVACE 2021)

Abstract

The drug design aims to generate chemical species that meet specific criteria, in-cluding efficacy against a pharmacological target, good safety profile, appropriate chemical and biological properties, sufficient novelty to ensure intellectual proper-ty rights for commercial success, etc. Using new algorithms to design and evalu-ate molecules in silicon de novo drug design is increasingly seen as an effective means of reducing the size of the chemical space to something more manageable for identifying chemogenomic research tool compounds and for use as starting points for hit-to-lead optimization.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kopecký, J., Boček, K., Vlachová, D.: Chemical structure and biological activity on m-and p-disubstituted derivatives of benzene [20]. Nature 207, 981 (1965)

    Article  Google Scholar 

  2. Wessel, M.D., Jurs, P.C., Tolan, J.W., Muskal, S.M.: Prediction of human intestinal absorption of drug compounds from molecular structure. J. Chem. Inf. Comput. Sci. 38, 726–735 (1998)

    Article  Google Scholar 

  3. Schneider, G., Schuchhardt, J., Wrede, P.: Artificial neural networks and simulated molecular evolution are potential tools for sequence-oriented protein design. Bioinformatics 10, 635–645 (1994)

    Article  Google Scholar 

  4. Ho, T.K.: Random decision forests. In: Proceedings of the International Conference on Document Analysis and Recognition, ICDAR, pp. 278–282 (1995)

    Google Scholar 

  5. Schölkopf, B.: SVMs - A practical consequence of learning theory. IEEE Intelligent Systems Their Appl. 13, 18–21 (1998)

    Google Scholar 

  6. Schneider, G.: Virtual screening: An endless staircase? Nat. Rev. Drug Discovery 9, 273–276 (2010)

    Article  Google Scholar 

  7. Scior, T., et al.: Recognizing pitfalls in virtual screening: a critical review. J. Chem. Inf. Model. 52, 867–881 (2012)

    Article  Google Scholar 

  8. Gómez-Bombarelli, R., et al.: Automatic chemical design using a data-driven continuous representation of molecules. ACS Cent. Sci. 4, 268–276 (2018)

    Article  Google Scholar 

  9. Ain, Q.U., Aleksandrova, A., Roessler, F.D., Ballester, P.J.: Machine-learning scoring functions to improve structure-based binding affinity prediction and virtual screening. Wiley Interdisciplinary Reviews: Computational Molecular Science 5, 405–424 (2015)

    Google Scholar 

  10. Schneider, G.: Future de novo drug design. Mol. Inf. 33, 397–402 (2014)

    Article  MathSciNet  Google Scholar 

  11. Segall, M.: Advances in multiparameter optimization methods for de novo drug design. Expert Opin. Drug Discov. 9, 803–817 (2014)

    Article  Google Scholar 

  12. Sessa, L., Nardiello, A.M., Santoro, J., Concilio, S., Piotto, S.: Hydroxylated fatty acids: the role of the sphingomyelin synthase and the origin of selectivity. Membranes 11, 787 (2021)

    Article  Google Scholar 

  13. Piotto, S., Sessa, L., Iannelli, P., Concilio, S.: Computational study on human sphingomyelin synthase 1 (hSMS1). Biochim. Biophys. Acta 1859, 1517–1525 (2017)

    Article  Google Scholar 

  14. Huang, S., Ernberg, I., Kauffman, S.: Cancer attractors: a systems view of tumors from a gene network dynamics and developmental perspective. Semin. Cell Dev. Biol. 20, 869–876 (2009)

    Article  Google Scholar 

  15. Serra, R., Villani, M., Barbieri, A., Kauffman, S.A., Colacci, A.: On the dynamics of random Boolean networks subject to noise: attractors, ergodic sets and cell types. J. Theor. Biol. 265, 185–193 (2010)

    Article  MathSciNet  MATH  Google Scholar 

  16. Lopez, D.H., et al.: 2-Hydroxy arachidonic acid: a new non-steroidal anti-inflammatory drug. PLoS ONE 8, e72052 (2013)

    Article  Google Scholar 

  17. Piotto, S., et al.: Differential effect of 2-hydroxyoleic acid enantiomers on protein (sphingomyelin synthase) and lipid (membrane) targets. Biochimica et Biophysica Acta (BBA) - Biomembranes 1838, 1628–1637 (2014)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stefano Piotto .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Piotto, S., Sessa, L., Santoro, J., Di Biasi, L. (2022). Artificial Chemical Neural Network for Drug Discovery Applications. In: Schneider, J.J., Weyland, M.S., Flumini, D., Füchslin, R.M. (eds) Artificial Life and Evolutionary Computation. WIVACE 2021. Communications in Computer and Information Science, vol 1722. Springer, Cham. https://doi.org/10.1007/978-3-031-23929-8_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-23929-8_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-23928-1

  • Online ISBN: 978-3-031-23929-8

  • eBook Packages: Computer ScienceComputer Science (R0)

Publish with us

Policies and ethics